Company Monitoring Page for Cempra

latest headlines for company on cafepharma

These five biotech CEOs earned big bucks even as their companies tanked
Stat
Fri, 05/5/17 - 10:33 am
Tags:
biotech, executive pay, Seres Therapeutics, Pacira, Ophthotech, Cempra, Endo International
Top Biopharma Movers of the Past Week
Yahoo/24-7 Wall St
Sun, 02/26/17 - 01:05 pm
Tags:
EyeGate Pharma, Trevena, Valeant Pharmaceuticals, Cempra
Biotech's Top 3 Stock Losers, and Winners, in 2016
Forbes
Mon, 01/2/17 - 12:03 pm
Tags:
biotech, Concordia, Ophthotech, Cempra, Corbus Pharmaceuticals, CoLucid, AveXis
Faced with a dilemma, the FDA rejects Cempra’s antibiotic, demands big safety study
Endpoints
Thu, 12/29/16 - 10:12 am
Tags:
FDA, Cempra, antibiotics, Solithromycin
Cempra Rises on Late-Stage Trial
Yahoo/24-7 Wall St
Mon, 12/5/16 - 09:57 am
Tags:
Cempra, clinical trials, Solithromycin, community acquired bacterial pneumonia
Will FDA approve a new antibiotic despite ‘significant’ safety issues?
Stat/Pharmalot
Mon, 11/7/16 - 09:14 pm
Tags:
FDA, antibiotics, Solithromycin, Cempra
FDA panel narrowly backs Cempra antibiotic
Yahoo/AP
Sat, 11/5/16 - 09:26 am
Tags:
FDA, advisory panels, Cempra, antibiotics, Solithromycin
Cempra shares plummet ahead of FDA meeting on antibiotic
Yahoo/AP
Wed, 11/2/16 - 10:20 pm
Tags:
Cempra, FDA, antibiotics, Solithromycin
Cempra Releases Promising Phase II Clinical Trial Results For Anti-NASH Drug
Xtalks
Wed, 10/5/16 - 05:25 pm
Tags:
Cempra, clinical trials, NASH, liver disease, Solithromycin
Could Cempra's Solithromycin Become The Largest Selling Antibiotic In History?
Seeking Alpha
Mon, 09/5/16 - 10:02 am
Tags:
Cempra, Solithromycin, antibiotics, community acquired bacterial pneumonia
​Chapel Hill drug developer Cempra looks to raise $200M
Bizjournals.com
Wed, 01/6/16 - 07:58 pm
Tags:
Cempra, R&D
How a Chapel Hill drug developer almost doubled its value in two months
Bizjournals.com
Tue, 12/8/15 - 11:21 am
Tags:
Cempra
Cempra’s New Drug Holds Potential, but Risk for Investors
TheStreet.com
Fri, 10/30/15 - 11:14 am
Tags:
Cempra, Solithromycin, FDA, antibiotics
3 Biotech Stocks to Buy With Huge Catalysts Coming Soon
24/7 Wall St
Mon, 08/3/15 - 12:17 pm
Tags:
Biomarin, drisapersen, Cempra, Solithromycin, antibiotics, Tetraphase Pharmaceuticals, Eravacycline
Chapel Hill drug developer Cempra sees stock bounce on pneumonia trial
Bizjournals.com
Tue, 07/7/15 - 10:30 am
Tags:
Cempra, community acquired bacterial pneumonia, Solithromycin
2 Biotech Buyout Candidates as Antibiotics Stop Working
24/7 Wall St
Mon, 05/4/15 - 09:39 am
Tags:
biotech, antibiotics, antibiotic resistance, Tetraphase Pharmaceuticals, Cempra
Japanese patent to infuse $10M into Chapel Hill drug developer
Bizjournals.com
Mon, 04/27/15 - 09:54 am
Tags:
Japan, patents, Cempra, CABP, community acquired bacterial pneumonia, Toyama
Analyst’s Top 3 Biotech Picks for 2015 With Upside and Takeover Potential
24/7 Wall St
Fri, 01/9/15 - 10:44 am
Tags:
M&A, Cempra, Jazz Pharmaceuticals, Kite Pharma
Cempra Oral Antibiotic Effective Against Hard-to-Treat Pneumonia
TheStreet.com
Mon, 01/5/15 - 09:10 am
Tags:
Cempra, antibiotics, Solithromycin, community acquired bacterial pneumonia
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
TheStreet.com
Wed, 12/17/14 - 10:02 am
Tags:
Biogen Idec, Bluebird Bio, Arrowhead Research, Vertex Pharmaceuticals, Cempra, CTI BioPharma, Gilead Sciences, Merck, Bristol-Myers Squibb, Sarepta Therapeutics, Neurocrine Biosciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.